Authors
Loading...
New technology integrates RPA amplification and CRISPR/Cas13d for sensitive PRRSV-1 detection, enhancing point-of-care testing.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: